Mechanisms of Leukocyte Integrin Signaling

白细胞整合素信号传导机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Uncontrolled neutrophil adhesion and activation contributes to significantly to tissue damage in inflammatory diseases such as rheumatoid arthritis and vasculitis. Integrins are the major adhesive receptors on neutrophils that regulate cellular activation. Investigating the basic mechanisms of neutrophil integrin signaling is therefore critical to our understanding of the pathogenesis of inflammatory disease. This application is focused on the "outside-in" integrin signaling pathway that induces neutrophil and macrophage activation. In previous work, we have demonstrated that outside-in integrin signaling is mediated by Src-family and Syk tyrosine kinases. In turn, these enzymes signal to SLP-76 leading to downstream activation of MAP kinases. The sequential involvement of Src-family kinases, Syk and SLP-76 is reminiscent of classical immunoreceptor signaling, such as B or T-cell receptor pathways, which depends on ITAM-containing adapter proteins. In preliminary data, we have found that neutrophils derived from DAP-12-/- FcRgamma-/- mice, which lack the two major ITAM adapters present in myeloid cells, are also completely defective in neutrophil integrin signaling. Based on these observations we hypothesize that leukocyte outside-in integrin signaling mimics classical immunoreceptor signaling pathways. We will test this hypothesis is a series of genetic and biochemical experiments. Using retroviral-mediated fetal liver hematopoietic stem cell transduction, we will introduce a series of mutant versions of Syk and DAP-12 into syk-/- or DAP-12-/- FcRgamma-/- mice that will test whether ITAM-Syk interactions are required for integrin signaling in primary neutrophils and macrophages. We will also test whether beta2 integrins form a complex with ITAM-containing DAP-12 and Syk, using biochemical methods and FRET-based microscopy techniques. If Syk and DAP12/FcRgamma are critical in outside-in integrin signaling, then deficiency of these molecules should result in equivalent defects in inflammatory processes in vivo. We will test this using two disease models that are known to be integrin dependent. If our hypothesis that integrin outside-in signaling mimics immunoreceptor pathways by use of ITAM molecules is validated, this will significantly change the view of integrin function in neutrophil-dependent inflammation. Therapeutic targeting of the integrin outside-in signaling pathway may provide novel classes of anti-inflammatory drugs.
描述(由申请人提供):不受控制的中性粒细胞粘附和激活对炎症性疾病(如类风湿关节炎和血管炎)的组织损伤有重要作用。整合素是中性粒细胞上调节细胞活化的主要粘附受体。因此,研究中性粒细胞整合素信号传导的基本机制对我们理解炎症性疾病的发病机制至关重要。该应用集中于诱导中性粒细胞和巨噬细胞活化的“由外而内”整合素信号通路。在之前的工作中,我们已经证明了src家族和Syk酪氨酸激酶介导了外向内整合素信号传导。反过来,这些酶向SLP-76发出信号,导致下游MAP激酶的激活。src家族激酶、Syk和SLP-76的顺序参与让人想起经典的免疫受体信号传导,如B或t细胞受体途径,这依赖于含有itam的适配蛋白。在初步数据中,我们发现来自DAP-12-/- FcRgamma-/-小鼠的中性粒细胞,缺乏髓细胞中存在的两种主要ITAM适配器,在中性粒细胞整合素信号传导方面也完全缺陷。基于这些观察,我们假设白细胞外-内整合素信号通路模拟经典的免疫受体信号通路。我们将通过一系列的基因和生化实验来检验这一假设。利用逆转录病毒介导的胎肝造血干细胞转导,我们将引入一系列Syk和ap -12的突变版本到Syk -/-或ap -12-/- FcRgamma-/-小鼠中,以测试ITAM-Syk相互作用是否需要在原代中性粒细胞和巨噬细胞中进行整合素信号传导。我们还将使用生化方法和基于fret的显微镜技术测试β 2整合素是否与含有DAP-12和Syk的itam形成复合物。如果Syk和DAP12/FcRgamma在外向内整合素信号传导中起关键作用,那么这些分子的缺乏应该会导致体内炎症过程中相应的缺陷。我们将使用两种已知的依赖于整合素的疾病模型来测试这一点。如果我们关于整合素外向内信号通过ITAM分子模拟免疫受体途径的假设得到验证,这将显著改变整合素在中性粒细胞依赖性炎症中的功能。整合素外-内信号通路的治疗靶点可能提供新型抗炎药物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Clifford A Lowell其他文献

Clifford A Lowell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Clifford A Lowell', 18)}}的其他基金

Regulation of Innate Immune Signaling by Lyn Kinase
Lyn 激酶对先天免疫信号的调节
  • 批准号:
    9208733
  • 财政年份:
    2015
  • 资助金额:
    $ 35.91万
  • 项目类别:
Regulation of Innate Immune Signaling by Lyn Kinase
Lyn 激酶对先天免疫信号的调节
  • 批准号:
    8870727
  • 财政年份:
    2015
  • 资助金额:
    $ 35.91万
  • 项目类别:
Regulation of Innate Immune Signaling by Lyn Kinase
Lyn 激酶对先天免疫信号的调节
  • 批准号:
    8997442
  • 财政年份:
    2015
  • 资助金额:
    $ 35.91万
  • 项目类别:
Signal Transduction in the Immune System-FASEB Summer Conference
免疫系统中的信号转导-FASEB夏季会议
  • 批准号:
    7748769
  • 财政年份:
    2009
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mechanisms of Leukocyte Integrin Signaling
白细胞整合素信号传导机制
  • 批准号:
    7531183
  • 财政年份:
    2007
  • 资助金额:
    $ 35.91万
  • 项目类别:
Neutrophil Function Core
中性粒细胞功能核心
  • 批准号:
    7531184
  • 财政年份:
    2007
  • 资助金额:
    $ 35.91万
  • 项目类别:
FASEB Summer Conference on Signal Transduction in the Immune System
FASEB 免疫系统信号转导夏季会议
  • 批准号:
    7274661
  • 财政年份:
    2007
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mechanisms of Leukocyte Integrin Signaling
白细胞整合素信号传导机制
  • 批准号:
    7531177
  • 财政年份:
    2006
  • 资助金额:
    $ 35.91万
  • 项目类别:
Neutrophil Function Core
中性粒细胞功能核心
  • 批准号:
    7531178
  • 财政年份:
    2006
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mechanisms of Neutrophil Activation
中性粒细胞激活机制
  • 批准号:
    8607877
  • 财政年份:
    2005
  • 资助金额:
    $ 35.91万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了